|
Report Date : |
02.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
DELTA PHARMA LTD. |
|
|
|
|
Registered Office : |
House-501, Road - 34, New DOHS, Mohakhali, Dhaka-1206 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
17.06.1964 |
|
|
|
|
Com. Reg. No.: |
C-2172 |
|
|
|
|
Legal Form : |
Public
Limited Company |
|
|
|
|
Line of Business : |
Manufacturer & Exporter of Medicine & Drugs including Tab, Capsules, Syrup, Suspension & Ointment. |
|
|
|
|
No. of Employees : |
1100 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Bangladesh |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Bangladesh - ECONOMIC OVERVIEW
In real terms
Bangladesh's economy has grown 5.8% per year since 1996 despite political instability,
poor infrastructure, corruption, insufficient power supplies, and slow
implementation of economic reforms. Bangladesh remains a poor, overpopulated,
and inefficiently-governed nation. Although more than half of GDP is generated
through the service sector, 45% of Bangladeshis are employed in the agriculture
sector with rice as the single-most-important product. Bangladesh's growth was
resilient during the 2008-09 global financial crisis and recession. Garment
exports, totaling $12.3 billion in FY09 and remittances from overseas
Bangladeshis, totaling $11 billion in FY10, accounted for almost 12% of GDP.
|
Source : CIA |
01. Name : Delta Pharma Limited
02. Address : Faluar Char, Tarakandi, Pakundia,
Kishoregonj,
Bangladesh.
03.
Head Office
: House-501, Road - 34, New DOHS, Mohakhali,
Dhaka-1206,
Bangladesh.
Phone-88-02-
9892192, 8711645-7
Fax-88-02-8750959
2-D/11-C,
Extension Pallabi, Road# 8, Mirpur 11 ˝, Dhaka-1216, Bangladesh.
Tel:
88-02-9010113, 01817157257
04. Telephone :
88-02-9892192, 8711645, 8711646, 8711647,
01713039874
05. Fax :
88-02-8750959
06. Website
: www.deltapharmabd.com
07. E-mail : info@deltapharmabd.com
intlmarketing@deltapharmabd.com
08. Factory Address :
Village-Tarakandi, Upazilla-Pakundia,
District-Kishoreganj, Bangladesh.
09. Distribution
Office
: Dhaka, Narayanganj, Comilla, Noakhali,
Chittagong,
Sylhet, Mymensingh, Tangail. Bogra, Rangpur, Rajshahi, Khulna, Jessore,
Faridpur & Barishal.
10. Established :
17.06.1964
11. Legal Form (General) : Public
12. Legal Form
(Specific)
: LTD
13. Issuing Authority : Registrar of Joint
Stock Companies & Firms
14. Incorporation No. : C-2172
15.
Listed at Stock Exchange : No
16. Employees :
1100 Persons.
17. Bank :
Islami Bank Bangladesh Ltd.
Mohakhali
Branch
Janani
Bhaban, 62 Shahid Tajuddin Sarani, Mohakhali, Dhaka -1212
Phone:
(02) 9883346, 8829400
Mobile:
01711-693917
Email:
mohakhali@islamibankbd.com
Dutch
Bangla Bank Ltd.
Mohakhali
Branch
Hotel
Zakaria (1st Floor), 35 Gulshan Road, Mohakhali C/A, Dhaka - 1212
18. Activities :
Manufacturer & Exporter of Medicine & Drugs.
19. Item dealings
in :
Tab, Capsules, Syrup, Suspension & Ointment.
20. Production
Capacity :
N/A
21. Last year
production :
N/A
22. Main Foreign
Buyers : N/A
23. Imported From : Vietnam,
Myanmar, Kenya, Nigeria, Panama, Peru Srilanka, Egypt, Hong Kong, Combodia,
Moritus, Uganda, Sudan, Yemen, Nepal, UAE, Guattemala & Costarica.
24. Name of the Group :
Nil
25. Name of the
Sister Concerns :
Nil
26. Type of
Office : Commercial Office Bldg.
27. Offices Area :
6500 Sq. Ft. (Own)
28. Factory Area :
10 bighas (approx.) (Own)
29. Warehouse Area : Do.
30. Names of
Shareholders :
Mrs. Ferdousi Akhter-10000 Shares
Mrs.
Nazneen Akhter-1000 Shares
Mrs.
Nadira Begum-1000 Shares
Mrs.
Rifat Hossain-30000 Shares
Others
Shareholder-2440000 Shares
31. Names of Directors : Mrs.
Ferdousi Akhter- Chairman
Dr. Md. Zakir Hossain- Managing Director
Mrs.
Nazneen Akhter-Director
Mrs. Nadira Begum- Director
Prof. Abdul Bayes Bhuiyan-Director
Mrs. Monira Jahan- Director
Mr. Golam Farook- Director
Mrs. Rifat Hossain- Director
32. Authorized
Capital :
Tk. 100 Crore
33. Paid up
Capital :
Tk. 25,00,00,000
34. Each Share
value :
Tk. 100.00 each
35. Last year
turnover :
Tk. 325 Million (July’11~ June’12)
36. Total
Liability :
Nil (July’11~ June’12)
37. Total Assets :
Tk. 80 Crore (July’11~ June’12)
38. Certified by : ISO 9001:2008
39. Purchasing Terms : 100% against confirmed & irrevocable
Letter of
Credit Payable at Sight
40. Member :
Dhaka Chamber of Commerce & Industry, Dhaka
41. Exchange Rate : USD 1 = Tk.84.3
GBP 1 = Tk.133.4553
EUR 1 = Tk.110.9219
JPY 1=Tk.1.1060
CNH 1=Tk.3.3958
AUD 1=90.1841
42. The person
Parting Information : Mr. Md. Sajid Iqbal-Admin Officer
43. General
Comments
: The subject is
public limited but not listed company
engaged in Manufacturer & Exporter of
Medicine & Drugs. The factory was situated in Faluar Char, Tarakandi,
Pakundia, Kishoregonj, Bangladesh. They are financially solvent and good at
their business commitment, it is reported. They get good support from their
Banks
Dr. Md. Zakir Hossain- Managing Director of
the company. He knows his job well.
We checked the local registry office &
found that information.
The company is ok for normal business
engagements.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.93 |
|
|
1 |
Rs.102.39 |
|
Euro |
1 |
Rs.85.12 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.